August 3, 2021 (Newswire.com) –
SiO2 Supplies Science, a privately owned U.S.-based superior supplies science firm, immediately introduced the appointment of Paul Fehlman as Chief Monetary Officer to assist ongoing efforts to quickly increase the enterprise.
Fehlman has over 30 years of expertise in numerous government monetary roles at public corporations main extremely efficient groups, elevating capital, driving superior money flows, interacting with buyers, bankers, and score companies, and creating worth by strategic M&A, danger administration, and steady enchancment on the operations stage. He most lately served as CFO at AZZ Inc. for six years and for 13 years at Flowserve Company in a number of positions together with VP Treasurer, FP&A, and Investor Relations, in addition to VP Finance of the most important working division of this industrial producer.
Fehlman’s appointment comes at a interval of fast progress for SiO2. In June of 2020, the corporate was awarded a $143 million contract from the U.S. authorities to offer vials for over 100 million doses of COVID-19 vaccine. In lower than six months, the corporate efficiently scaled manufacturing efforts 12-fold to ship the vials. The corporate now has over 30 clients within the Biopharmaceutical and Molecular Diagnostic house.
Mike Harrison who has served as the corporate’s Chief Monetary Officer since March 2020 will proceed as a part of the corporate’s senior management and can tackle the function of Chief Accounting Officer and Treasurer.
SiO2 is now centered on bringing its technology-enabled good vials, syringes, cartridges, and blood assortment tubes to market to assist next-generation biologics, liquid biopsies, and different in-vitro diagnostic functions.
“Biologics are advanced medication and the present packaging, which hasn’t developed in over 100 years, is unable to assist them in probably the most optimum method,” stated Fehlman. “Drug innovation is extremely vital for society and I’m very excited to hitch an organization that empowers biopharma and diagnostic innovators with the containment techniques they should carry their improvements to life.”
Over the previous 10 years, SiO2 has spent greater than $500 million in analysis and improvement to invent its breakthrough supplies science platform which fuses the advantages of glass and plastic with out the drawbacks of both. Right this moment, the fabric is being utilized by dozens of consumers and is seeing fast adoption all through the biopharma and molecular diagnostic industries.
“We’re extremely excited to have Paul be a part of SiO2 as we speed up our progress plans,” stated Robert Abrams, Chief Government Officer at SiO2. “He’s an extremely gifted particular person and we stay up for working collectively to assist innovators within the biopharma and molecular diagnostic areas to carry their improvements to life with out the restrictions of conventional glass.”
About SiO2 Supplies Science:
SiO2 Supplies Science is a sophisticated supplies science company introducing breakthrough disruptive know-how serving the biopharma, molecular diagnostic, and shopper healthcare industries. The corporate is positioned in Auburn, Alabama.
Supply: SiO2 Supplies Science